BRD2 and polycystic ovary syndrome: Several pathways discovered only in patients/models with PCOS concerning FSH receptors and insulin/IGF have been researched, which may help to explain the phenomenon that the ovarian response to FSH preparations tends to decrease with the increasing IR degree only in patients with PCOS (31, 39, 40).